A new paradigm to understand and treat diabetic neuropathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 4, 2014, Pages 201-207

  Hidmark, A ^a   Fleming, T ^a   Vittas, S ^a   Mendler, M ^a   Deshpande, D ^a   Groener, J B ^a   Muller B P ^b   Reeh, P W ^c   Sauer, S K ^c   Pham, M ^b   Muckenthaler, M U ^b   Bendszus, M ^b   Nawroth, P P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

metabolic features; neuropathy; oxidative stress; receptors

Indexed keywords

4 HYDROXYNONENAL; ACROLEIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGEN TYPE 4; CROTONALDEHYDE; CYCLOOXYGENASE 2; FERRITIN; FIBRONECTIN; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; K RAS PROTEIN; LACTOYLGLUTATHIONE LYASE; LAMININ; MALONALDEHYDE; METHYLGLYOXAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; SODIUM CHANNEL NAV1.8; SUPEROXIDE DISMUTASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UBIQUINOL CYTOCHROME C REDUCTASE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; GLUCOSE BLOOD LEVEL; GLYOXAL; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; CHRONIC PAIN; DIABETIC NEUROPATHY; DIABETIC PATIENT; EXCITOTOXICITY; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MEMBRANE STEADY POTENTIAL; METABOLITE; NERVE CELL DEGENERATION; NERVE CELL EXCITABILITY; NERVE CELL LESION; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SCIATIC NERVE INJURY; UPREGULATION; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; METABOLISM;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; HUMANS; RECEPTORS, IMMUNOLOGIC;

EID: 84899625870     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1367023     Document Type: Article

References (80)

1. Hoffmann F., Icks a. Diabetes epidemic in Germany? A critical look at health insurance data sources. Exp. Clin. Endocrinol. Diabetes [Internet]: 2012; 120 410 415 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22441721
2. Callaghan B. C., Cheng H. T., Stables C. L. et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol [Internet] Elsevier Ltd: 2012; [cited 2013 Mar 7] 11 521 534 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608666
3. Callaghan B. C., Little A. A., Feldman E. L. et al. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev [Internet]: 2012; [cited 2013 May 10] 6 CD007543. Available from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007543.pub2/pdf/standard
4. Ismail-Beigi F., Craven T., Banerji M. A. et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet [Internet]. Elsevier Ltd: 2010; [cited 2013 Mar 4] 376 419 430 Available from: http://www.ncbi.nlm.nih.gov/ pubmed/20594588
5. Turner R., Holman R., Cull C. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet [Internet]: 1998; [cited 2013 Mar 6] 352 837 853 Available from http://discovery.ucl.ac.uk/1310755/ (Pubitemid 28416718)
6. Duckworth W., Abraira C., Moritz T. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med [Internet]: 2009; 360 129 39 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19092145
7. Bongaerts BW C., Rathmann W., Kowall B. et al. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study. Diabetes Care [Internet]: 2012; [cited 2013 May 6] 35 1891 1893 Available from http://www.ncbi.nlm.nih.gov/pubmed/22751964
8. Lu B., Hu J., Wen J. et al. Determination of Peripheral Neuropathy Prevalence and Associated Factors in Chinese Subjects with Diabetes and Pre-Diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS). PLoS One [Internet]: 2013; [cited 2013 May 26] 8 e61053 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3628856&tool=pmcentrez&rendertype=abstract
9. Fleming T., Cuny J., Nawroth G. et al. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates? Diabetologia [Internet]: 2012; [cited 2013 Jan 31] 55 1151 1155 Available from http://www.ncbi.nlm.nih.gov/pubmed/22270223
10. Thornalley P. J., Jahan I., Ng R. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem [Internet]: 2001; 129 543 549 Available from http://www.ncbi.nlm.nih.gov/pubmed/11275553 (Pubitemid 32299275)
11. Thurston J. H., McDougal D. B., Hauhart R. E. et al. Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve. Relation to mechanisms of peripheral neuropathy. Diabetes [Internet]: 1995; [cited 2013 Jun 22] 44 190 195 Available from http://www.ncbi.nlm.nih.gov/pubmed/7859940
12. Thornalley P. J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems - role in ageing and disease. Drug Metabol Drug Interact [Internet]: 2008; [cited 2013 Jun 22] 23 125 150 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2649415&tool=pmcentrez&rendertype=abstract (Pubitemid 351669568)
13. Lo T. W., Westwood M. E., McLellan A. C. et al. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J Biol Chem [Internet]: 1994; [cited 2013 Jun 22] 269 32299 32305 Available from http://www.ncbi.nlm.nih.gov/ pubmed/7798230
14. Thornalley P. J. The Clinical Significance of Glycation. Clin Lab: 1999; 45 263 273 (Pubitemid 29253774)
15. Vlassara H., Brownlee M., Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci U S A [Internet]: 1981; 78 5190 5192 Available from http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=320369&tool=pmcentrez&rendertype=abstract (Pubitemid 12229699)
16. Vlassara H., Brownlee M., Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes [Internet]: 1983; [cited 2013 Jun 22] 32 670 674 Available from http://www.ncbi.nlm.nih.gov/pubmed/6862112 (Pubitemid 13062852)
17. Williams S. K., Howarth N. L., Devenny J. J. et al. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc Natl Acad Sci U S A [Internet]: 1982; [cited 2013 Jun 22] 79 6546 6550 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 347164&tool=pmcentrez&rendertype=abstract (Pubitemid 13207531)
18. Cullum N. A., Mahon J., Stringer K. et al. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia [Internet]: 1991; [cited 2013 Jun 22] 34 387 389 Available from http://www.ncbi.nlm.nih.gov/ pubmed/1715829
19. Sugimoto K., Nishizawa Y., Horiuchi S. et al. Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation endproduct. Diabetologia [Internet]: 1997; [cited 2013 Jun 22] 40 1380 1387 Available from http://www.ncbi.nlm.nih.gov/pubmed/9447944 (Pubitemid 28004930)
20. Ryle C., Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci [Internet]: 1995; [cited 2013 Jun 22] 129 62 68 Available from http://www.ncbi.nlm.nih.gov/pubmed/7751847
21. Ryle C., Leow C. K., Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve [Internet]: 1997; [cited 2013 Jun 22] 20 577 584 Available from http://www.ncbi.nlm.nih.gov/pubmed/9140364 (Pubitemid 27190749)
22. Sensi M., Morano S., Morelli S. et al. Reduction of advanced glycation end-product (AGE) levels in nervous tissue proteins of diabetic Lewis rats following islet transplants is related to different durations of poor metabolic control. Eur J Neurosci [Internet]: 1998; [cited 2013 Jun 22] 10 2768 2775 Available from http://www.ncbi.nlm.nih.gov/pubmed/9758147 (Pubitemid 29073950)
23. Thornalley P. J., Battah S., Ahmed N. et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J [Internet]: 2003; 375 581 592 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1223712&tool= pmcentrez&rendertype=abstract (Pubitemid 37433506)
24. Bierhaus A., Fleming T., Stoyanov S. et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med [Internet]: 2012; [cited 2013 Mar 15] 18 926 933 Available from http://www.ncbi.nlm.nih.gov/pubmed/22581285
25. Rush A. M., Dib-Hajj S. D., Liu S. et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A [Internet]: 2006; [cited 2013 Jul 23] 103 8245 8250 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 1472458&tool=pmcentrez&rendertype=abstract (Pubitemid 43801083)
26. Rush A. M., Cummins T. R., Waxman S. G. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol [Internet]: 2007; [cited 2013 May 22] 579 1 14 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2075388&tool= pmcentrez&rendertype=abstract
27. Eberhardt M. J., Filipovic M. R., Leffler A. et al. Methylglyoxal activates nociceptors through TRPA1 - a possible mechanism of metabolic neuropathies. J Biol Chem [Internet]: 2012; Available from http://www.ncbi.nlm. nih.gov/pubmed/22740698
28. Thornalley P. J. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans [Internet]: 2003; 31 1343 1348 Available from http://www.ncbi.nlm.nih.gov/pubmed/14641060 (Pubitemid 38030973)
29. Jack M. M., Ryals J. M., Wright D. E. Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy. Diabetologia [Internet]: 2011; [cited 2013 Apr 19] 54 2174 2182 Available from http://www.ncbi.nlm.nih.gov/pubmed/21633909
30. Jack M. M., Ryals J. M., Wright D. E. Protection from diabetes-induced peripheral sensory neuropathy - a role for elevated glyoxalase I? Exp Neurol [Internet] Elsevier Inc: 2012; [cited 2013 Apr 19] 234 62 69 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3294099&tool= pmcentrez&rendertype=abstract
31. Skapare E., Konrade I., Liepinsh E. et al. Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients. J Diabetes Complications [Internet] Elsevier Inc: 2013; [cited 2013 Apr 19] 10 15 Available from http://www.ncbi.nlm.nih.gov/ pubmed/23351995
32. Groener J. B., Reismann P., Fleming T. et al. Hamann a, et al. C332C Genotype of Glyoxalase 1 and its Association with Late Diabetic Complications. Exp Clin Endocrinol Diabetes [Internet]: 2013; Available from http://www.ncbi.nlm.nih.gov/pubmed/23775136
33. Peculis R., Konrade I., Skapare E. et al. Identification of glyoxalase 1 polymorphisms associated with enzyme activity. Gene [Internet]. Elsevier B.V: 2013; [cited 2013 Apr 17] 515 140 143 Available from http://www.ncbi.nlm.nih. gov/pubmed/23201419
34. Morcos M., Du X., Pfisterer F. et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell [Internet]: 2008; [cited 2013 Mar 8] 7 260 269 Available from http://www.ncbi.nlm.nih.gov/pubmed/18221415 (Pubitemid 351359658)
35. Schlotterer A., Kukudov G., Bozorgmehr F. et al. C. elegans as Model for the Study of High Glucose - Mediated Life Span Reduction. Diabetes [Internet]. American Diabetes Association: 2009; 58 2450 2456 Available from http://dx.doi.org/10.2337/db09-0567
36. Mendler M., Schlotterer A., Morcos M. et al. Understanding diabetic polyneuropathy and longevity: what can we learn from the nematode Caenorhabditis elegans? Exp Clin Endocrinol Diabetes [Internet]: 2012; [cited 2013 May 9] 120 182 183 Available from http://www.ncbi.nlm.nih.gov/pubmed/8247153
37. Sima aaF. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci [Internet]: 2003; [cited 2013 Jun 22] 60 2445 2464 Available from http://www.ncbi.nlm.nih.gov/pubmed/14625688 (Pubitemid 37487263)
38. Vincent A. M., Feldman E. L. New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord [Internet]: 2004; [cited 2013 Jun 22] 5 227 236 Available from http://www.ncbi.nlm.nih.gov/pubmed/15211094 (Pubitemid 38903580)
39. Chammas M., Bousquet P., Renard E. et al. Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am [Internet]: 1995; [cited 2013 Jun 22] 20 109 114 Available from http://www.ncbi.nlm.nih.gov/pubmed/7722249
40. Kennedy J. M., Zochodne D. W. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain [Internet]: 2000; 123 2118 2129 Available from http://www.ncbi.nlm.nih. gov/pubmed/11004128
41. Stys P. K. General mechanisms of axonal damage and its prevention. J Neurol Sci [Internet]: 2005; [cited 2013 May 28] 233 3 13 Available from http://linkinghub.elsevier.com/retrieve/pii/S0022510×05000754 (Pubitemid 40804810)
42. Davies K. J. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp [Internet]: 1995; [cited 2013 Jun 22] 61 1 31 Available from http://www.ncbi.nlm.nih.gov/pubmed/8660387
43. Finkel T., Holbrook N. J. Oxidants, oxidative stress and the biology of ageing. Nature [Internet]: 2000; [cited 2013 May 29] 408 239 247 Available from http://www.ncbi.nlm.nih.gov/pubmed/11089981
44. Murphy M. P. How mitochondria produce reactive oxygen species. Biochem J [Internet]: 2009; [cited 2013 Jun 17] 417 1 13 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2605959&tool= pmcentrez&rendertype=abstract
45. Hentze M. W., Muckenthaler M. U., Galy B. et al. Two to tango: regulation of Mammalian iron metabolism. Cell [Internet]: 2010; [cited 2013 May 28] 142 24 38 Available from http://www.ncbi.nlm.nih.gov/pubmed/20603012
46. Forouhi N. G., Harding aH, Allison M. et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia [Internet]: 2007; [cited 2013 Jun 14] 50 949 956 Available from http://www.ncbi.nlm.nih.gov/pubmed/17333112 (Pubitemid 46559245)
47. Fernández-Real J. M., López-Bermejo A., Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes [Internet]: 2002; [cited 2013 Jul 5] 51 2348 2354 Available from http://www.ncbi.nlm.nih.gov/ pubmed/12145144 (Pubitemid 34827381)
48. Ford E. S., Cogswell M. E. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care [Internet]: 1999; [cited 2013 Jul 5] 22 1978 1983 Available from http://www.ncbi.nlm.nih.gov/pubmed/10587829 (Pubitemid 30433975)
49. O'Brien P. J., Siraki A. G., Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol [Internet]: 2005; [cited 2013 Jun 22] 35 609 662 Available from http://www.ncbi.nlm.nih.gov/pubmed/16417045 (Pubitemid 41693601)
50. Rabbani N., Thornalley P. J. Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids [Internet]: 2012; [cited 2013 Mar 2] 42 1133 1142 Available from http://www.ncbi.nlm.nih.gov/pubmed/20963454
51. Rosca M. G., Mustata T. G., Kinter M. T. et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol [Internet]: 2005; [cited 2013 Jun 27] 289 F420 F430 Available from http://www.ncbi.nlm.nih.gov/pubmed/15814529 (Pubitemid 41003672)
52. Rabbani N., Thornalley P. J. Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans [Internet]: 2008; [cited 2013 Jun 22] 36 1045 1050 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2639773&tool= pmcentrez&rendertype=abstract
53. Kapoor R., Davies M., Blaker Pa et al. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol [Internet]: 2003; [cited 2013 Jun 22] 53 174 180 Available from http://www.ncbi.nlm.nih.gov/pubmed/12557283 (Pubitemid 36163998)
54. Mack T. G., Reiner M., Beirowski B. et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci [Internet]: 2001; [cited 2013 May 31] 4 1199 1206 Available from http://www.ncbi.nlm.nih.gov/pubmed/11770485 (Pubitemid 33135625)
55. Adalbert R., Gillingwater T. H., Haley J. E. et al. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci [Internet]: 2005; [cited 2013 Jun 22] 21 271 277 Available from http://www.ncbi.nlm.nih.gov/pubmed/15654865 (Pubitemid 40193896)
56. Ikegami K., Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience [Internet]: 2003; [cited 2013 Jun 22] 122 617 626 Available from http://linkinghub.elsevier.com/retrieve/pii/S0306452203006687 (Pubitemid 37410283)
57. Sievers C., Platt N., Perry V. H. et al. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res [Internet]: 2003; [cited 2013 Jun 22] 46 161 169 Available from http://www.ncbi.nlm.nih.gov/pubmed/ 12767479 (Pubitemid 36593279)
58. Scholz J., Woolf C. J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci [Internet]: 2007; [cited 2013 May 31] 10 1361 1368 Available from http://www.ncbi.nlm.nih.gov/pubmed/17965656 (Pubitemid 350014681)
59. Cámara-Lemarroy C. R., Guzmán-de la Garza F. J., Fernández-Garza N. E. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neuroimmunomodulation [Internet]: 2010; [cited 2013 Jun 22] 17 314 324 Available from http://www.ncbi.nlm.nih.gov/ pubmed/20407283
60. Gaudet A. D., Popovich P. G., Ramer M. S. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation [Internet] BioMed Central Ltd: 2011; [cited 2013 Jun 22] 8 110 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 3180276&tool=pmcentrez&rendertype=abstract
61. Greene D. A., Sima A. A., Stevens M. J. et al. Complications: neuropathy, pathogenetic considerations. Diabetes Care [Internet]: 1992; [cited 2013 Jun 22] 15 1902 1925 Available from http://www.ncbi.nlm.nih.gov/pubmed/1464245
62. Feldman E. L., Stevens M. J., Greene D. A. Pathogenesis of diabetic neuropathy. Clin Neurosci [Internet]: 1997; [cited 2013 Jun 22] 4 365 370 Available from http://www.ncbi.nlm.nih.gov/pubmed/9358981 (Pubitemid 27465449)
63. Wellen K. E., Hotamisligil G. S. Inflammation, stress, and diabetes. J Clin Invest [Internet]: 2005; [cited 2013 Jun 19] 115 1111 1119 Available from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1087185&tool= pmcentrez&rendertype=abstract (Pubitemid 40629025)
64. Hotamisligil G. S. Inflammation and metabolic disorders. Nature [Internet]: 2006; [cited 2013 May 21] 444 860 867 Available from http://www.ncbi.nlm.nih.gov/pubmed/17167474 (Pubitemid 46024993)
65. Matarese G., Procaccini C., De Rosa V. At the crossroad of T cells, adipose tissue, and diabetes. Immunol Rev [Internet]: 2012; 249 116 134 Available from http://www.ncbi.nlm.nih.gov/pubmed/22889219
66. Zhou J., Zhou S. Inflammation: Therapeutic Targets for Diabetic Neuropathy. Mol Neurobiol [Internet]: 2013; [cited 2013 Nov 11]; (August). Available from http://www.ncbi.nlm.nih.gov/pubmed/23990376
67. Sims G. P., Rowe D. C., Rietdijk S. T. et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol [Internet]: 2010; [cited 2013 May 23] 28 367 388 Available from http://www.ncbi.nlm.nih.gov/pubmed/20192808
68. Tang D., Kang R., Coyne C. B. et al. PAMPs and DAMPs: signal 0 s that spur autophagy and immunity. Immunol Rev [Internet]: 2012; 249 158 175 Available from http://www.ncbi.nlm.nih.gov/pubmed/22889221
69. Fleming T. H., Humpert P. M., Nawroth P. P. et al. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology [Internet]: 2011; [cited 2013 Jan 31] 57 435 443 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20962515
70. Bierhaus A., Nawroth P. P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia [Internet]: 2009; [cited 2013 May 31] 52 2251 2263 Available from: http://www.ncbi.nlm.nih. gov/pubmed/19636529
71. Bierhaus A., Humpert P. M., Morcos M. et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) [Internet]: 2005; [cited 2013 May 24] 83 876 886 Available from: http://www.ncbi.nlm.nih.gov/ pubmed/16133426 (Pubitemid 41598688)
72. Xu D., Kyriakis J. M. Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products. J Biol Chem [Internet]: 2003; [cited 2013 Jun 27] 278 39349 39355 Available from: http://www.ncbi.nlm.nih.gov/pubmed/12871951 (Pubitemid 37248490)
73. Yeh C. H., Sturgis L., Haidacher J. et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes [Internet]: 2001; [cited 2013 Jun 27] 50 1495 1504 Available from: http://www.ncbi.nlm.nih.gov/ pubmed/11375353 (Pubitemid 32500185)
74. Kierdorf K., Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol [Internet]: 2013; [cited 2013 May 30] 94 1 14 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23543766
75. Mahajan N., Dhawan V. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases. Int J Cardiol [Internet] Elsevier Ireland Ltd: 2013; [cited 2013 Jun 4] Available from http://www.ncbi.nlm.nih. gov/pubmed/23722052
76. Bierhaus A., Haslbeck K., Humpert P. M. et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest [Internet]: 2004; [cited 2013 May 10] 114 1741 1751 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=535062&tool= pmcentrez&rendertype=abstract (Pubitemid 40385530)
77. Lukic I. K., Humpert P. M., Nawroth P. P. et al. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann N Y Acad Sci [Internet]: 2008; [cited 2013 May 30] 1126 76 80 Available from http://www.ncbi.nlm.nih.gov/pubmed/18448798 (Pubitemid 351589321)
78. Pham M., Oikonomou D., Bäumer P. et al. Proximal neuropathic lesions in distal symmetric diabetic polyneuropathy: findings of high-resolution magnetic resonance neurography. Diabetes Care [Internet]: 2011; [cited 2013 Mar 19] 34 721 723 Available from http://www.pubmedcentral.nih.gov/articlerender. fcgi?artid=3041214&tool=pmcentrez&rendertype=abstract
79. Juranek J. K., Geddis M. S., Song F. et al. RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice. Diabetes [Internet]: 2013; [cited 2013 Apr 29] 62 931 943 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23172920
80. Duran-Jimenez B., Dobler D., Moffatt S. et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes [Internet]: 2009; [cited 2013 May 10] 58 2893 2903 Available from: http://diabetes.diabetesjournals.org/content/58/12/ 2893.short